Elisabeth Mathiesen is Professor of Endocrinology, chief physician and associate professor in the faculty of health science, University of Copenhagen, Rigshospitalet, Denmark. She is also head of diabetes treatment at the Copenhagen Centre for Pregnant Women with Diabetes, working with gestational and pregestational diabetes.
Professor Mathiesen’ research focuses on pregnant women with type 1 and type 2 diabetes, focusing on prevention of pre-eclampsia, preterm delivery and stillbirth. Specifically, her research involves investigating the beneficial effects of strict metabolic control; the use of insulin analogues and continuous glucose monitoring in pregnancy; the risk of women with previous GDM developing diabetes and the metabolic syndrome; the risk to children of women with high glucose concentrations in the intrauterine environment due to diabetes during pregnancy, and the beneficial effect of treatment of pregnant women with kidney involvement with antihypertensive drugs as well as pre-eclampsia.
Professor Mathiesen has published more than 200 scientific papers and supervised six PhD students. She is a member of the European Association for the Study of Diabetes, the European Diabetes in Pregnancy Study Group, the European Diabetic Nephropathy Study Group, the Danish Endocrine Society, Danish Society of Internal Medicine and the Danish Society for Hypertension, Pre-existing Diabetes and Pregnancy.